In our search for trigger(s) of TRAF6 activation during development of pathological cardiac hypertrophy, we focused on the production of ROS because of its key role in various cardiovascular diseases, including Ang II- or pressure overload-induced cardiac hypertrophy20, 21, 37, 38. This evidence concerns the gene AGT and cardiovascular disorder.